Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Director, Access Strategy & Marketing will lead the development and execution of access strategy, value proposition development, and execution of marketing materials for the RevMed NSCLC portfolio (daraxonrasib, zoldonrasib and elironrasib). This role will focus on developing the short to medium term non-clinical value proposition across payers, HCPs, organized customers (GPOs, IDNs, etc) and channel partners. This role will be instrumental in supporting a successful launch through effective launch planning, tailored messaging to various customer types, and working cross-functionally with Market Access, Brand Marketing, Medical/HEOR, Regulatory and Compliance partners. The ideal candidate will also have experience in translating a dynamic policy and reimbursement landscape into access strategies over the product lifecycle (ie, impact of IRA, MFN, etc).
This position is based out of our headquarters in Redwood City, CA. Remote candidates may be considered on case-by-case basis.
Responsibilities may include:
Developing and aligning with cross-functional partners on the three-year access strategy across RevMed’s NSCLC portfolio.
Lead the creation of value proposition messaging and materials tailored for payers, PBMs, IDNs, GPOs, channel partners, and other key managed care decision-makers.
Partner with national account field team to educate on access strategy and available resources.
Work closely with Brand Marketing, Regulatory and Compliance to ensure all materials support brand goals and follow compliance guidelines.
Required Skills, Experience and Education:
Bachelor’s degree required with 8-10+ years of experience in managed care strategy and marketing.
Experience in new product launches, including both high level strategy development and tactical execution.
Strong understanding of access landscape across all market access stakeholders.
Track record of being a collaborative team player, and adaptive to meet the needs of a growing business.
Excellent organizational skills and an ability to prioritize effectively to deliver results within reasonably established timelines.
Ability to represent Revolution Medicines well: strong interpersonal skills including verbal and written communication.
Ability to travel up to 25%.
Preferred Skills:
10+ years of experience in Marketing and/or Managed Care.
Oral Oncolytic product experience strongly preferred.
Deep understanding of US public policy and reimbursement dynamics.
Prior experience with developing co-positioning strategy across multiple assets and identifying portfolio tradeoffs.
Prior experience in customer-facing roles.
#LI-Remote #LI-SS2
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Similar Jobs
What you need to know about the Los Angeles Tech Scene
Key Facts About Los Angeles Tech
- Number of Tech Workers: 375,800; 5.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Snap, Netflix, SpaceX, Disney, Google
- Key Industries: Artificial intelligence, adtech, media, software, game development
- Funding Landscape: $11.6 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Strong Ventures, Fifth Wall, Upfront Ventures, Mucker Capital, Kittyhawk Ventures
- Research Centers and Universities: California Institute of Technology, UCLA, University of Southern California, UC Irvine, Pepperdine, California Institute for Immunology and Immunotherapy, Center for Quantum Science and Engineering
